INVA

Innoviva, Inc.

Pharmaceuticals · Pharmaceuticals

$155.98 sample

-0.71 (-0.45%) 1D

Market cap

$352.9B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-17

Alerts

8

Price$155.98 -3.94% 3M daily closessample

170.78153.87

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: Chief Financial Officer
Oct 05INSInsider sell: EVP, Operations
Sep 25INSInsider buy: 10% owner
Sep 22INSInsider sell: Chief Financial Officer
Sep 17SECDEF 14A filed
Sep 11INSInsider buy: General Counsel
Sep 02SECForm 144 filed
Aug 25INSInsider sell: Chief Financial Officer

Sign up to see the real INVA record →

Company facts

SEC EDGAR registration

Name: Innoviva, Inc.
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: -46sample, -100 to +100
Reporting currency: USD

Who is positioning in INVA

sample

Insiders: 25 insider transactions over 90 days, net selling, $44.6M
Congress: 3 members traded over 90 days
Institutions · 13F: 25 funds hold $3.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.7B +16.1% y/y

Q4 2024Q3 2026

Inventory$13.3B +9.5% y/y

Q4 2024Q3 2026

Accounts receivable$10.0B +6.9% y/y

Q4 2024Q3 2026

Total debt$28.9B +15.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $319.4B +8.9% 3M
Sample peer B: $44.9B +14.0% 3M
Sample peer C: $299.0B +8.6% 3M
Sample peer D: $215.7B +14.4% 3M
Sample peer E: $255.8B +8.2% 3M